These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16491358)

  • 1. Engineering biosynthetic pathways to generate antitumor indolocarbazole derivatives.
    Sánchez C; Méndez C; Salas JA
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):560-8. PubMed ID: 16491358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial biosynthesis of antitumor indolocarbazole compounds.
    Sánchez C; Zhu L; Braña AF; Salas AP; Rohr J; Méndez C; Salas JA
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):461-6. PubMed ID: 15625109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolocarbazole antitumour compounds by combinatorial biosynthesis.
    Salas JA; Méndez C
    Curr Opin Chem Biol; 2009 Apr; 13(2):152-60. PubMed ID: 19251468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of indolocarbazole and goadsporin, two different heterocyclic antibiotics produced by actinomycetes.
    Onaka H
    Biosci Biotechnol Biochem; 2009 Oct; 73(10):2149-55. PubMed ID: 19809190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the late steps in the biosynthesis of the anti-tumour indolocarbazole staurosporine: sugar donor substrate flexibility of the StaG glycosyltransferase.
    Salas AP; Zhu L; Sánchez C; Braña AF; Rohr J; Méndez C; Salas JA
    Mol Microbiol; 2005 Oct; 58(1):17-27. PubMed ID: 16164546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis.
    Sánchez C; Braña AF; Méndez C; Salas JA
    Chembiochem; 2006 Aug; 7(8):1231-40. PubMed ID: 16874749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biosynthetic gene cluster for the antitumor rebeccamycin: characterization and generation of indolocarbazole derivatives.
    Sánchez C; Butovich IA; Braña AF; Rohr J; Méndez C; Salas JA
    Chem Biol; 2002 Apr; 9(4):519-31. PubMed ID: 11983340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin.
    Anizon F; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T; Aubertin AM
    Bioorg Med Chem; 1998 Sep; 6(9):1597-604. PubMed ID: 9801830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of bisindole biosynthetic pathways by combinatorial construction.
    Du YL; Ryan KS
    ACS Synth Biol; 2015 Jun; 4(6):682-8. PubMed ID: 25548949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and functional modification of StaC and RebC, which are involved in the pyrrole oxidation of indolocarbazole biosynthesis.
    Asamizu S; Shiro Y; Igarashi Y; Nagano S; Onaka H
    Biosci Biotechnol Biochem; 2011; 75(11):2184-93. PubMed ID: 22056432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staurosporine and rebeccamycin aglycones are assembled by the oxidative action of StaP, StaC, and RebC on chromopyrrolic acid.
    Howard-Jones AR; Walsh CT
    J Am Chem Soc; 2006 Sep; 128(37):12289-98. PubMed ID: 16967980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures and catalytic mechanism of cytochrome P450 StaP that produces the indolocarbazole skeleton.
    Makino M; Sugimoto H; Shiro Y; Asamizu S; Onaka H; Nagano S
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11591-6. PubMed ID: 17606921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonenzymatic oxidative steps accompanying action of the cytochrome P450 enzymes StaP and RebP in the biosynthesis of staurosporine and rebeccamycin.
    Howard-Jones AR; Walsh CT
    J Am Chem Soc; 2007 Sep; 129(36):11016-7. PubMed ID: 17705392
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological targets of antitumor indolocarbazoles bearing a sugar moiety.
    Prudhomme M
    Curr Med Chem Anticancer Agents; 2004 Nov; 4(6):509-21. PubMed ID: 15579016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine.
    Nakano H; Omura S
    J Antibiot (Tokyo); 2009 Jan; 62(1):17-26. PubMed ID: 19132059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumor antibiotic rebeccamycin-challenges and advanced approaches in production processes.
    Pommerehne K; Walisko J; Ebersbach A; Krull R
    Appl Microbiol Biotechnol; 2019 May; 103(9):3627-3636. PubMed ID: 30888461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic organization of the biosynthetic gene cluster for the indolocarbazole K-252a in Nonomuraea longicatena JCM 11136.
    Kim SY; Park JS; Chae CS; Hyun CG; Choi BW; Shin J; Oh KB
    Appl Microbiol Biotechnol; 2007 Jul; 75(5):1119-26. PubMed ID: 17396254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA targeting of two new antitumour rebeccamycin derivatives.
    Facompré M; Baldeyrou B; Bailly C; Anizon F; Marminon C; Prudhomme M; Colson P; Houssier C
    Eur J Med Chem; 2002 Dec; 37(12):925-32. PubMed ID: 12660017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolocarbazole protein kinase C inhibitors from rebeccamycin.
    Fabre S; Prudhomme M; Sancelme M; Rapp M
    Bioorg Med Chem; 1994 Feb; 2(2):73-7. PubMed ID: 7922125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.